Fastic, Starlix, Starsis, nateglinide (YM026)

Also known as: A-4166

General Information

Company	Novartis AG
Description	D-phenylalanine amino acid derivative
Molecular Target	ATP-dependent potassium channel (KATP)
Mechanism of Action	ATP-dependent potassium channel (KATP) blocker

Latest Stage of Development	Marketed
Indication	Diabetes
Partner	Ajinomoto Co. Inc.; Astellas Pharma Inc.; Daiichi Sankyo Co. Ltd.

Product Details

Archive Items are loading